Staphylococcus aureus produces four types of ,-lactamase (A, B, C, and D). To (13, 14, 16, 20, 21, 24, 25, 27 
D P-lactamase was distinguishably lower (10.1 for types A, B, and C and 9.7 for type D). We conclude that marked differences in the stability of commonly used j3-lactams to hydrolysis by the staphylococcal 1-lactamases are present. This heterogeneity and the clinical implications thereof need to be considered in the antibiotic management of staphylococcal infection.
Four variants of Staphylococcus aureus P-lactamase have been identified by using immunologic methods (25) (26) (27) and more recently by using substrate profile techniques (13, 14) . Although substrate profile determinations are useful in identifying and distinguishing P-lactamases, other methods, including isoelectric focusing, have proven useful in enzyme characterization. Furthermore, additional important information regarding P-lactam-,-lactamase interactions can be obtained from a more detailed kinetic evaluation of the enzymes (3, 4) . In this article, we report the isoelectric points of the different staphylococcal P-lactamases, along with kinetic parameters of the P-lactamase-antimicrobial interaction, including Michaelis constants (Km values) and turnover numbers (kcat values) for various ,-lactam substrates. Marked differences in the kinetics of hydrolysis of commonly used penicillin and cephalosporin agents by the different staphylococcal 1-lactamases exist and may explain, in part, why some staphylococcal infections fail to respond to ,B-lactam therapy.
MATERIALS AND METHODS Microorganisms. Strains that produce each of the four recognized variants of S. aureus ,B-lactamase were used as the source of P-lactamase for kinetic determinations and isoelectric focusing. These included the following variants and strains: type A, PC1(pl524) and RN11(pI258); type B, 22260; type C, V137; and type D, FAR8 and FAR10. The pedigrees of these isolates have been described previously (13, 14, 16, 20, 21, 24, 25, 27 ).
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Antimicrobial agents and media. Standard powders of nitrocefin (BBL Microbiology Systems, Cockeysville, Md.), cephaloridine (Sigma Chemicals, St. Louis, Mo.), cefuroxime (Glaxo, Inc., Research Triangle Park, N.C.), methicillin, ampicillin, and cephapirin (Bristol Laboratories, Syracuse, N.Y.), and cefazolin, cefamandole, cephalothin, and penicillin G (Eli Lilly and Company, Indianapolis, Ind.) were used to prepare antimicrobial solutions for kinetic determinations. Modified 1% CY broth was prepared as described previously (14, 20) .
13-Lactamase preparations. Extracellular ,B-lactamase was purified from each of the six S. aureus isolates by sequential cation-exchange and affinity chromatography (7, 15 (22) . After 2 h, the gels were removed from the soaking solution and left uncovered at room temperature to permit evaporation of excess fluid, until they were within 5% of their original weight. Standard applicator strips (LKB) were used to apply 20 ,ul of the samples and high-range pI markers (LKB) to the gel. Electrophoresis was performed at 10°C by using preset limit values of 1400 V, 10 mA, and 10 W for 60 min. The gels were fixed in a 0.7 M perchloric acid solution (60 ml of 70% perchloric acid per liter). Destaining and staining (Coomassie blue) procedures were performed by previously described protocols (22) .
RESULTS
,-Lactamase purification and specific activity. The type A (strain PC1), B (strain 22260), C (strain V137), and D (strain FAR10) ,-lactamases were purified by sequential cationexchange and affinity chromatography (7, 15) . The (Table 1) . Km values of the four enzymes for penicillin G and ampicillin were higher but also relatively homogeneous. The substrate profile determined from relative kcat values (Table 3) failed to discriminate between the various enzymes as effectively as substrate profiles determined with a single concentration (100 1iM) of each antibiotic (13, 14) . This difference results from the relative inefficiency of hydrolysis of 100 ,uM cefazolin by the type B and C enzymes, both of which exhibit Km values greater than 250 p.M. We have previously reported cefazolin/cephaloridine hydrolysis ratios of 79, 12, 14, and 116% for the type A, B, C, and D The relative efficiency of hydrolysis (REH) (4) of each substrate was determined from the ratio of the two physical constants (kcat/Km) of the 1-lactamase-antibiotic interaction (Table 4 ). In general, the penicillins were hydrolyzed more efficiently than the cephalosporins by each of the ,B-lactamases; however, marked differences among the various cephalosporins were also noted. More than a 2,000-fold difference between the REH values of cefazolin and cefuroxime by the type A 3-lactamase was determined. This greatly exceeds the 60-fold difference in the stability of penicillin G and cefazolin with the same enzyme.
Isoelectric focusing. Successful isoelectric focusing of staphylococcal r3-lactamase required purification to homogeneity and the utilization of protein-staining techniques instead of activity assays (e.g., nitrocefin overlay) for band identification. When a commercially prepared gel with a high pH range was utilized, the type A and D P-lactamases each had an apparent isoelectric point of 9.2 ( Fig. 1) . However, because of the observed aggregation at the application site and the possibility that the true pl of the ,B-lactamases might exceed the upper pH range of the commercial gels, the protocol was modified to include presoaking of the gel in Triton X-100 and high-pH ampholytes prior to electrophoresis. By these methods, higher pl values were observed, and the type A and D variants could be distinguished by a (3, 4) . In this report, we have described the kinetics of hydrolysis of nine substrates, including penicillin, ampicillin, and seven cephalosporins, by the four recognized P-lactamases of S. aureus. None of the cephalosporins that we evaluated was available during the mid-1960s when Richmond originally described the kinetic characteristics of the type A, B, and C enzymes (25) .
Our finding that the type A, B, and C ,B-lactamases exhibit comparable activity against penicillin G differs from the report by Richmond that the type B P-lactamase has only 15% of the activity of the type A and C enzymes (25) . Since we purified the type B P-lactamase from a reference strain (22260) that had been serotyped as type B by Rosdahl (27) , it is unlikely that the observed discrepancy can be explained as an erroneous determination of P-lactamase type. Differences in methodology, including replacement of the fixed-time iodometric assays used for determining penicillinase activity during the 1960s with more accurate initial velocity of hydrolysis assays with recording spectrophotometers, may be contributory and make direct comparisons between studies difficult.
We found that the type D ,3-lactamase exhibits considerably less rapid hydrolysis of penicillin G than do the other ,-lactamases. This observation complements our previous report of differences in the substrate profiles of the type A and D P-lactamases (13, 14) . Indeed, for P-lactamase typing assays employing whole-cell bacterial suspensions (13), we now use the penicillin G/cephaloridine hydrolysis ratio instead of the nitrocefin/cefazolin hydrolysis ratio to rapidly differentiate between strains making the type A versus the type D P-lactamase. Penicillin G/cephaloridine ratios of 90 + 10 and 30 + 5 enable clearer discrimination between the type A and D enzymes, respectively (our unpublished data).
As illustrated by the REH data (Table 4) , some P-lactamases hydrolyze specific cephalosporins relatively efficiently.
For example, the type B and C P-lactamases exhibit a higher REH of cephaloridine, but a lower REH of cefazolin, than the type A enzyme. S. aureus strains that exhibit a marked inoculum effect with cephaloridine (1, 30) and cefazolin (9, 10, 30) have been described. We have previously reported that the highest MICs of cephaloridine are associated with isolates producing the type B and C enzymes (14) , whereas for type A strains, MICs of cefazolin were greatest (12, 14)-these observations are consistent with the kinetic data.
Similarly, type A 1-lactamase-producing S. aureus isolates exhibit a more profound inoculum effect with cefazolin than with cefamandole, whereas type B and C 1-lactamaseproducing strains display the reverse relationship (12, 14) . Although sole consideration of the kcat values without other kinetic parameters favors that each of the staphylococcal ,B-lactamases should degrade cefazolin much more rapidly than they degrade cefamandole, marked differences between the cefazolin Km values for the type A enzyme and those for the type B and C enzymes exist. Therefore, when the REH values are compared, the type A P-lactamase exhibits fivefold greater activity against cefazolin than against cefamandole, whereas the type B and C 1-lactamases degrade cefamandole about three times more efficiently than cefazolin ( Table 4 ). The association of type A and type C P-lacta- VOL. 36, 1992 on June 21, 2017 by guest http://aac.asm.org/ Downloaded from mase-producing strains of S. aureus with sternal wound infections complicating cefazolin and cefamandole prophylaxis, respectively, has been reported (12) . The correlation between the clinical and kinetic data suggests that the enzymatic reaction may contribute to the clinical observations. These assessments may oversimplify the pharmacodynamic interactions, however, since other factors such as the relative potency of the antibiotics, etc., also influence MIC results.
Studies of antibiotic therapy in animal models of S. aureus endocarditis have differed in showing that cefazolin is equivalent (5, 6) or inferior (11) in efficacy to cephalothin. Whereas the REH values of cefazolin and cephalothin by the type B and C ,-lactamases are comparable, the type A and D P-lactamases hydrolyze cefazolin about 25 times more efficiently than they do cephalothin (Table 4 ). The type(s) of 3-lactamase produced by the strains used in the in vivo endocarditis studies was not identified, and it is possible that both observations are correct and that the discordant results are due, in part, to differences in ,B-lactamase type among the S. aureus strains evaluated. Although controlled clinical trials have not been performed, the kinetic data suggest that other more stable P-lactams may be preferable to cefazolin in treating serious infections due to type A 3-lactamaseproducing strains of S. aureus.
This study confirms the observation of previous investigators that there are marked differences in the stability of the various cephalosporins against hydrolysis by the staphylococcal 3-lactamases (9, 10, 23, 29, 30) . Indeed, the 2,000-fold difference in the REH values of cefazolin and cefuroxime by the type A P-lactamase greatly exceeds the 60-fold difference between the stability of cefazolin and that of penicillin G.
Such data make it abundantly clear that the 1-lactamase stability of various cephalosporin and penicillin antibiotics represents a continuum. Arbitrary designations of antistaphylococcal antibiotics as 3-lactamase stable versus labile oversimplify the observed heterogeneity of enzyme-substrate interactions and should be avoided.
One of the most challenging aspects of this investigation was the development of a methodology for the isoelectric focusing of the S. aureus 3-lactamases. Although three studies have reported isoelectric points ranging from 8.7 to 9.55 for the type A 3-lactamase, details of the methods by which these values were determined were described in only the report by Schaeg et al. (18, 26, 31) . Our early attempts to perform isoelectric focusing on the staphylococcal P-lactamases involved the use of both impure P-lactamase preparations (i.e., concentrated broth supernatant) and standard techniques involving the use of nitrocefin-impregnated filter paper (19) . Although a streak of P-lactamase activity extending across the lower pH range of the gel was observed, a precise pI band could not be identified (our unpublished observations). An additional technical problem that we encountered involves the marked reduction in enzyme activity exhibited by staphylococcal P-lactamase at pH values approaching and exceeding 9.0 (24), i.e., the ,-lactamase lacks enzymatic activity at its pl. Accordingly, it may be difficult to identify the pl of staphylococcal P-lactamase by nitrocefin overlay techniques following gel electrophoresis. By soaking the nitrocefin-imprognated filter paper in an acidic buffer (0.5 M sodium citrate, pH 5.0) prior to applying the filter paper to the gel (i.e., to counteract the ampholytes in the gel), we were able to extend the streak of f-lactamase activity observed following isoelectric focusing into the high pH range. The broad streak of P-lactamase activity prevented a precise pl determination.
As described in Results, we subsequently performed isoelectric focusing with purified preparations of staphylococcal ,-lactamase by using protein stains rather than enzymatic activity for band recognition. By using modified techniques for gel presoaking and staining, we observed distinctive pl values of 10.1 and 9.7 for the purified type A and D ,-lactamases, respectively (Fig. 2) . The different pls are consistent with the reported 5-amino-acid difference in the primary structures of the type A and type D P-lactamases (8) . Why the observed pl of the type A enzyme differs so much with different methods of isoelectric focusing (i.e., from 9.2 to 10.1) is unclear. Possibly the addition of Triton X-100 to the gel modified tertiary enzyme structure, leading to partial unfolding and exposure of internal basic residues. At present, the requirement for enzyme purification, as well as the identical pl values of the type A, B, and C enzymes, limits the utility of isoelectric focusing in discriminating between the S. aureus f-lactamases.
In summary, the four recognized S. aureus P-lactamases can be distinguished kinetically. This work clearly demonstrates the heterogeneity in ,-lactamase stability of commonly used penicillin and cephalosporin antibiotics. This heterogeneity and the clinical implications thereof need to be considered in the prevention and therapy of staphylococcal infections.
